Want to be in the know about the latest advances in diabetes research? Need more information on how to live well with T1D? Connect with us on social networking sites, subscribe to our emails, and check out our print and online materials.
Cool Research News
- White House Honors Tidepool for Its Development of T1D Data Technology
New apps help simplify T1D management Tidepool™—a JDRF-supported nonprofit committed to reducing the burden of type 1 diabetes (T1D)—has received a White House Champion of Change Precision Medicine Award for its work to develop innovative, open-source software and mobile phone apps that help people with T1D better manage the disease. The technologies will provide tools […]
- One Drug’s To-Do List Could Grow
An osteoporosis medication could help restore insulin production in people with type 1 diabetes Type 1 diabetes (T1D) is caused by an autoimmune attack on insulin-producing beta cells, but studies have shown that many adults with long-term T1D are able to maintain some of their beta cells. One potential approach to curing the disease is […]
- 2015 JDRF Children’s Congress Day Three Recap
After three days of advocacy, education and networking, the 2015 JDRF Children’s Congress is over. All 163 of our delegates and their families are traveling back to their home states and countries, spanning Alaska to Australia, having left an indelible mark on hundreds of Members of Congress. Yesterday morning, our delegates and their families got […]
- 2015 JDRF Children’s Congress Day Two Recap
After months of anticipation and a lot of hard work, we’re finally ready to storm Capitol Hill! Yesterday was the final day of preparation for our 163 delegates. Today, JDRF Advocacy staff gave region-specific training to our delegates on how to have the most impactful Hill visits possible. We want every Senator and Congressperson to […]
- Day one of 2015 JDRF Children’s Congress is a wrap!
This is Brian Herrick and Kady Helme reporting each day from 2015 JDRF Children’s Congress. Yesterday was a travel day for most of our delegates and staff, who came from all 50 states and 6 countries to Washington, D.C. to speak with one voice about the importance of continued federal funding for T1D research. Over […]